Tandem Diabetes executive chairman: Global uncertainity may cause investor hesitation
Kim Blickenstaff, the executive chairman of Tandem Diabetes Care, joins Jim Cramer to discuss how the company keepsย ...
Chief Human Resources Officer, Tandem Diabetes Care
Search every verified Tom Fox interview, podcast appearance, and on-the-record quote โ each transcript cross-checked by AI and human review to confirm speaker identity. Tom Fox, Chief Human Resources Officer at Tandem Diabetes Care, has not been quoted in the provided material. The transcript and quotes feature Kim Blickenstaff, the company's executive chairman, discussing business performance and strategy in a September 2019 interview. Blickenstaff stated that the company's sales rates accelerated from Q1 to Q2 and that fundamentals remained intact. He attributed growth partly to converting daily insulin injectors to pump users, noting that about 30% of type 1 diabetics use a pump. Blickenstaff also addressed manufacturing decisions, saying the company keeps production in San Diego to maintain quality control and coordination with development engineers. He expressed a preference for manufacturing in America for this product. Regarding future products, he predicted FDA approval within the year and said a launch would be "almost instantaneous" due to the Tandem Device Updater, which enables software upgrades without hardware changes. He mentioned gaining traction in Europe and that clinical trial results presented at the American Diabetes Association had generated broad awareness in the medical community.
“All of our fundamentals are intact and in fact, our sales rates in Q2 accelerated from Q1, so we're in an acceleration mode and I don't think people really appreciate that.”
“We need to control the product quality; that's very important. There's a very unique device and we need to have our manufacturing near our development engineers so there's proper coordination and good focus on quality, so that's why it's here in San Diego.”
“That's the way I feel about this particular product: if you want great quality, you have to make it in America.”
“About 30% of type 1 diabetics are using a pump, so we are going to expand that market where we actually are calling those daily injectors coming over to a pump. That was a big part of our growth.”
Kim Blickenstaff, the executive chairman of Tandem Diabetes Care, joins Jim Cramer to discuss how the company keepsย ...
Sign in to search the full transcript archive, filter by topic, and access every quote from Tom Fox.